Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

ALT

10 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in Altimmune, Inc.

No. Qube Research & Technologies exited its ALT (Altimmune) position in Q4 2023. Its Q3 2023 13F listed 178,697 shares worth $464,612. Qube Research & Technologies first reported ALT in Q3 2020 and held it in 8 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$197,000

Total Shares Change

-14,889

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2023-Q4
Latest
Exited
0
-100.0%
$00.0%$11.25
0
2023-Q3
Decreased
178,697
-80.4%
$464,6120.0%$2.60
0
2023-Q2
Increased
910,239
+33.3%
$3.2M0.0%$3.53
34
2023-Q1
Increased
682,680
+5298.8%
$2.9M0.0%$4.22
42
2022-Q4
Decreased
12,645
-63.4%
$208,0100.0%$16.45
0
2022-Q3
New
34,579
-
$442,0000.0%$12.77
33
2021-Q2
Exited
0
-100.0%
$00.0%$9.85
0
2021-Q1
Decreased
17,645
-76.3%
$249,0000.0%$14.13
0
2020-Q4
Increased
74,358
+399.4%
$839,0000.0%$11.28
40
2020-Q3
New
14,889
-
$197,0000.0%$13.20
32

Other major holders of ALT: State Street Corp., Janus Henderson Group Ltd., BlackRock, Inc., Nuveen Asset Management, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used